- €1.68bn
- €3.40bn
- €1.60bn
- 77
- 80
- 89
- 97
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,458 | 1,368 | 1,430 | 1,521 | 1,597 |
Cost of Revenue | |||||
Gross Profit | 1,012 | 946 | 960 | 1,063 | 1,146 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,258 | 1,231 | 1,242 | 1,251 | 1,333 |
Operating Profit | 201 | 137 | 189 | 270 | 264 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 175 | 102 | 156 | 257 | 200 |
Provision for Income Taxes | |||||
Net Income After Taxes | 142 | 85.2 | 144 | 224 | 181 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 143 | 92 | 144 | 225 | 181 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 143 | 92 | 144 | 225 | 181 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.304 | 0.261 | 0.307 | 0.271 | 0.312 |
Dividends per Share | |||||
Special Dividends per Share |